{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:59:14Z","timestamp":1791831554593,"version":"4.3.4"},"reference-count":115,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005930","name":"ASCRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jcrsjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jcrs.2019.03.023","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T02:06:07Z","timestamp":1556244367000},"page":"669-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["An algorithm for the preoperative diagnosis and treatment of ocular surface disorders"],"prefix":"10.1097","volume":"45","author":[{"given":"Christopher E.","family":"Starr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeya K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Farid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Yeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.P.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D.","family":"Ayers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Berdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis S.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210210","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0002-9394(14)71688-5","article-title":"Prevalence of dry eye among the elderly.","volume":"124","author":"Schein","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R2-21-20210210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1542-0124(12)70224-0","article-title":"Post-LASIK tear dysfunction and dysesthesia.","volume":"8","author":"Nettune","year":"2010","journal-title":"Ocul Surf"},{"key":"R4-21-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ophtha.2017.10.003","article-title":"American Academy of Ophthalmology Preferred Practice Pattern Refractive ManagementIntervention Panel. Refractive errors refractive surgery Preferred Practice Pattern.","volume":"125","author":"Chuck","year":"2018","journal-title":"Ophthalmology"},{"key":"R5-21-20210210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2015.10.047","article-title":"Comprehensive adult medical eye evaluation Preferred Practice Pattern guidelines.","volume":"123","author":"Feder","year":"2016","journal-title":"Ophthalmology"},{"key":"R6-21-20210210","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2147\/OPTH.S120159","article-title":"The Prospective Health Assessment of Cataract Patients Ocular Surface (PHACO) study: the effect of dry eye.","volume":"11","author":"Trattler","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R7-21-20210210","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jcrs.2018.06.026","article-title":"Prevalence of ocular surface dysfunction in patients presenting for cataract surgery.","volume":"44","author":"Gupta","year":"2018","journal-title":"J Cataract Refract Surg"},{"key":"R8-21-20210210","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jcrs.2009.01.031","article-title":"Dissatisfaction after multifocal intraocular lens implantation.","volume":"35","author":"Woodward","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"R9-21-20210210","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jcrs.2015.01.016","article-title":"Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning.","volume":"41","author":"Epitropoulos","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R10-21-20210210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report.","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul Surf"},{"key":"R11-21-20210210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"key":"R13-21-20210210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index.","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R14-21-20210210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/09273940701486803","article-title":"Ocular surface disease index for the diagnosis of dry eye syndrome.","volume":"15","author":"Ozcura","year":"2007","journal-title":"Ocul Immunol Inflamm"},{"key":"R15-21-20210210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","article-title":"Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses.","volume":"33","author":"Chalmers","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"key":"R16-21-20210210","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report.","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocul Surf"},{"key":"R17-21-20210210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index.","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"key":"R18-21-20210210","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ICO.0b013e318294b0c0","article-title":"Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire.","volume":"32","author":"Ngo","year":"2013","journal-title":"Cornea"},{"key":"R19-21-20210210","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/ICO.0b013e318191b870","article-title":"The relationship between dry eye symptoms and lipid layer thickness.","volume":"28","author":"Blackie","year":"2009","journal-title":"Cornea"},{"key":"R20-21-20210210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ICO.0000000000000712","article-title":"Ocular Surface Disease Index (OSDI) versus the Standard Patient Evaluation of Eye Dryness (SPEED): A study of a nonclinical sample.","volume":"35","author":"Asiedu","year":"2016","journal-title":"Cornea"},{"key":"R21-21-20210210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R22-21-20210210","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ajo.2010.10.032","article-title":"Tear osmolarity in the diagnosis and management of dry eye disease.","volume":"151","author":"Lemp","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R23-21-20210210","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1167\/iovs.10-5390","article-title":"An objective approach to dry eye disease severity.","volume":"51","author":"Sullivan","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-21-20210210","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2147\/OPTH.S95242","article-title":"Tear film osmolarity and dry eye disease: a review of the literature.","volume":"9","author":"Potvin","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"R25-21-20210210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ophtha.2014.07.048","article-title":"Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease.","volume":"122","author":"Aragona","year":"2015","journal-title":"Ophthalmology"},{"key":"R26-21-20210210","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/ICO.0000000000000175","article-title":"3rd, Friedberg M, Tauber S. Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease.","volume":"33","author":"Sambursky","year":"2014","journal-title":"Cornea"},{"key":"R27-21-20210210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","article-title":"3rd, Latkany R, Tauber S, Starr C, Friedberg M, Dirks MS, McDonald M. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye.","volume":"131","author":"Sambursky","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R28-21-20210210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","article-title":"The matrix metalloproteinase 9 point-of-care test in dry eye.","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul Surf"},{"key":"R29-21-20210210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000150445","article-title":"Inflammatory markers in the tears of patients with ocular surface disease.","volume":"40","author":"Acera","year":"2008","journal-title":"Ophthalmic Res"},{"key":"R30-21-20210210","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","article-title":"Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay.","volume":"123","author":"Messmer","year":"2016","journal-title":"Ophthalmology"},{"key":"R31-21-20210210","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1167\/iovs.13-12235","article-title":"Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis.","volume":"54","author":"Acera","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-21-20210210","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1167\/iovs.02-0766","article-title":"Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis.","volume":"44","author":"Leonardi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-21-20210210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9394(01)00913-8","article-title":"Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids.","volume":"132","author":"Dursun","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R36-21-20210210","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","article-title":"Inflammatory cytokines in the tears of patients with ocular rosacea.","volume":"104","author":"Barton","year":"1997","journal-title":"Ophthalmology"},{"key":"R37-21-20210210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/ICO.0b013e3182a7f3e1","article-title":"Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction.","volume":"32","author":"Finis","year":"2013","journal-title":"Cornea"},{"key":"R38-21-20210210","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jcrs.2011.03.036","article-title":"Objective optical assessment of tear-film quality dynamics in normal and mildly symptomatic dry eyes.","volume":"37","author":"Benito","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"R39-21-20210210","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome.","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"R40-21-20210210","doi-asserted-by":"crossref","first-page":"105117","DOI":"10.1016\/j.berh.2012.01.012","article-title":"Sjogrens syndrome, the old and the new.","volume":"26","author":"Peri","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R41-21-20210210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0004563217750679","article-title":"Predictive role of tear protein expression in the early diagnosis of Sjogrens syndrome.","volume":"55","author":"Versura","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"R42-21-20210210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogrens syndrome.","volume":"155","author":"Shen","year":"2014","journal-title":"Clin Immunol"},{"key":"R43-21-20210210","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogrens syndrome.","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol"},{"key":"R44-21-20210210","first-page":"223","article-title":"Displacement technique and meibomian gland expression.","volume":"58","author":"Hom","year":"1987","journal-title":"J Am Optom Assoc"},{"key":"R45-21-20210210","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/ICO.0b013e3181d4f366","article-title":"Nonobvious obstructive meibomian gland dysfunction.","volume":"29","author":"Blackie","year":"2010","journal-title":"Cornea"},{"key":"R46-21-20210210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00055735-200008000-00005","article-title":"The use of vital dyes in corneal disease.","volume":"11","author":"Kim","year":"2000","journal-title":"Curr Opin Ophthalmol"},{"key":"R47-21-20210210","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00003226-199905000-00015","article-title":"Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells.","volume":"18","author":"Kim","year":"1999","journal-title":"Cornea"},{"key":"R48-21-20210210","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0161-6420(95)30769-5","article-title":"Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal.","volume":"102","author":"Manning","year":"1995","journal-title":"Ophthalmology"},{"key":"R49-21-20210210","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary.","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"R51-21-20210210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/ICU.0000000000000227","article-title":"Mechanisms and management of dry eye in cataract surgery patients.","volume":"27","author":"Sutu","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"R52-21-20210210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9394(03)00326-X","article-title":"The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.","volume":"136","author":"Avunduk","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R53-21-20210210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R54-21-20210210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ICL.0000000000000049","article-title":"Effect of loteprednol etabonate 0.5 on initiation of dry eye treatment with topical cyclosporine 0.05.","volume":"40","author":"Sheppard","year":"2014","journal-title":"Eye Contact Lens"},{"key":"R55-21-20210210","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"R56-21-20210210","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","article-title":"OPUS-2 Investigators. Lifitegrast ophthalmic solution 5.0 versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study.","volume":"122","author":"Tauber","year":"2015","journal-title":"Ophthalmology"},{"key":"R57-21-20210210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/OPTH.S152841","article-title":"Ocular comfort assessment of lifitegrast ophthalmic solution 5.0 in OPUS-3, a phase III randomized controlled trial.","volume":"12","author":"Nichols","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R58-21-20210210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/OPTH.S126668","article-title":"Dry eye syndrome: developments and lifitegrast in perspective.","volume":"12","author":"Lollett","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R59-21-20210210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"R60-21-20210210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","article-title":"Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-ss2 production.","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"R61-21-20210210","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jcrs.2009.12.049","article-title":"Cyclosporine 0.05 to improve visual outcomes after multifocal intraocular lens implantation.","volume":"36","author":"Donnenfeld","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"R62-21-20210210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ophtha.2013.09.015","article-title":", OPUS-1 Study Group. Lifitegrast ophthalmic solution 5.0 for treatment of dry eye disease: results of the OPUS-1 phase 3 study.","volume":"121","author":"Sheppard","year":"2014","journal-title":"Ophthalmology"},{"key":"R63-21-20210210","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/14656566.2017.1372748","article-title":"Lifitegrast for the treatment of dry eye disease in adults.","volume":"18","author":"Donnenfeld","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"R64-21-20210210","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"issue":"Suppl 2","key":"R65-21-20210210","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S0039-6257(00)00205-8","article-title":"The treatment of dry eye.","volume":"45","author":"Calonge","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R66-21-20210210","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1517\/13543784.2013.838557","article-title":"Changing trends in the treatment of dry-eye disease.","volume":"22","author":"Dogru","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"R67-21-20210210","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0014-4835(03)00005-8","article-title":"Minocycline effect on meibomian gland lipids in meibomianitis patients.","volume":"76","author":"Shine","year":"2003","journal-title":"Exp Eye Res"},{"key":"R68-21-20210210","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00003226-200308000-00011","article-title":"Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis.","volume":"22","author":"Ta","year":"2003","journal-title":"Cornea"},{"key":"R69-21-20210210","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.2006.091579","article-title":"Short term oral minocycline treatment of meibomianitis.","volume":"90","author":"Aronowicz","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R70-21-20210210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)71750-7","article-title":"Efficacy of doxycycline and tetracycline in ocular rosacea.","volume":"116","author":"Frucht-Pery","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R71-21-20210210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3109\/02713683.2012.683508","article-title":"Correlations among symptoms, signs, and clinical tests in evaporative-type dry eye disease caused by Meibomian gland dysfunction (MGD).","volume":"37","author":"Cuevas","year":"2012","journal-title":"Curr Eye Res"},{"key":"R72-21-20210210","doi-asserted-by":"crossref","first-page":"e105575","DOI":"10.1371\/journal.pone.0105575","article-title":"Meibomian gland dysfunction determines the severity of the dry eye conditions in visual display terminal workers.","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"R74-21-20210210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/OPTH.S132851","article-title":"Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin.","volume":"11","author":"Stroman","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R75-21-20210210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.ico.0000244870.62384.79","article-title":"Clinical treatment of ocular demodecosis by lid scrub with tea tree oil.","volume":"26","author":"Gao","year":"2007","journal-title":"Cornea"},{"key":"R76-21-20210210","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2147\/OPTH.S114674","article-title":"DEBS a unification theory for dry eye and blepharitis.","volume":"10","author":"Rynerson","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R77-21-20210210","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/ICO.0b013e318239aaea","article-title":"2nd, Silbert DI, Blackie CA, Stevens CA, Bedi R. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction.","volume":"31","author":"Lane","year":"2012","journal-title":"Cornea"},{"key":"R78-21-20210210","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/02713683.2011.631721","article-title":"A single LipiFlow Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months.","volume":"37","author":"Greiner","year":"2012","journal-title":"Curr Eye Res"},{"key":"R79-21-20210210","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/OPTH.S109663","article-title":"The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye.","volume":"10","author":"Blackie","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R80-21-20210210","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2147\/OPTH.S139894","article-title":"Intense pulsed light for evaporative dry eye disease.","volume":"11","author":"Dell","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R81-21-20210210","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e3181d836f3","article-title":"Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction.","volume":"29","author":"Maskin","year":"2010","journal-title":"Cornea"},{"key":"R82-21-20210210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/bjophthalmol-2016-310097","article-title":"Growth of meibomian gland tissue after intraductal meibomian gland probing in patients with obstructive meibomian gland dysfunction.","volume":"102","author":"Maskin","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R83-21-20210210","first-page":"811","article-title":"A randomized controlled trial of omega-3 fatty acids in dry eye syndrome.","volume":"6","author":"Bhargava","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"R84-21-20210210","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ophtha.2013.04.006","article-title":"Short-term consumption of oral omega-3 and dry eye syndrome.","volume":"120","author":"Kangari","year":"2013","journal-title":"Ophthalmol"},{"key":"R85-21-20210210","first-page":"169","article-title":"Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study.","volume":"8","author":"Olenik","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R86-21-20210210","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.","volume":"320","author":"Endres","year":"1989","journal-title":"N Engl J Med"},{"key":"R87-21-20210210","first-page":"1681","article-title":"Group, Asbell PA, Maguire MG, Pistilli M, Ying GS, Szczotka-Flynn LB, Hardten DR, Lin MC, Shtein RM. n-3 fatty acid supplementation for the treatment of dry eye disease.","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"key":"R88-21-20210210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1442-9071.2004.00782.x","article-title":"Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro.","volume":"32","author":"Cha","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"key":"R89-21-20210210","first-page":"795","article-title":"A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease.","volume":"10","author":"Friedman","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R90-21-20210210","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders.","volume":"88","author":"Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R91-21-20210210","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","article-title":"Treatment of persistent corneal epithelial defect by autologous serum application.","volume":"106","author":"Tsubota","year":"1999","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"R92-21-20210210","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICO.0b013e31817f3a0e","article-title":"Autologous serum eye drops for the treatment of dry eye diseases.","volume":"27","author":"Kojima","year":"2008","journal-title":"Cornea"},{"key":"R93-21-20210210","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease.","volume":"88","author":"Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R94-21-20210210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R95-21-20210210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/exer.1999.0794","article-title":"Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn.","volume":"70","author":"Kim","year":"2000","journal-title":"Exp Eye Research"},{"key":"R96-21-20210210","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1097\/ICL.0b013e318255124f","article-title":"Placement of ProKera in the management of ocular manifestations of acute Stevens-Johnson syndrome in an outpatient.","volume":"39","author":"Kolomeyer","year":"2013","journal-title":"Eye Contact Lens"},{"key":"R97-21-20210210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/ICL.0b013e3181a66a12","article-title":"Evaluation of the role of ProKera in the management of ocular surface and orbital disorders.","volume":"35","author":"Pachigolla","year":"2009","journal-title":"Eye Contact Lens"},{"key":"R98-21-20210210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/ICL.0b013e3182a2f8fa","article-title":"Sutureless amniotic membrane ProKera for ocular surface disorders: short-term results.","volume":"39","author":"Suri","year":"2013","journal-title":"Eye Contact Lens"},{"key":"R99-21-20210210","doi-asserted-by":"crossref","first-page":"6404918","DOI":"10.1155\/2017\/6404918","article-title":"Corneal nerve regeneration after self-retained cryopreserved amniotic membrane in dry eye disease.","volume":"2017","author":"John","year":"2017","journal-title":"J Ophthalmol"},{"key":"R100-21-20210210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2147\/OPTH.S162203","article-title":"Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study.","volume":"12","author":"McDonald","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R101-21-20210210","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/OPTH.S165553","article-title":"Amniotic membrane extract and eye drops: a review of literature and clinical application.","volume":"12","author":"Murri","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R102-21-20210210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clae.2003.09.004","article-title":"Efficacy of continuous wear PureVision contact lenses for therapeutic use.","volume":"27","author":"Arora","year":"2004","journal-title":"Cont Lens Anterior Eye"},{"key":"R103-21-20210210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.icl.0000174755.50802.15","article-title":"Therapeutic use of silicone hydrogel contact lenses in children.","volume":"32","author":"Bendoriene","year":"2006","journal-title":"Eye Contact Lens"},{"key":"R104-21-20210210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00006324-200306000-00007","article-title":"Management of filamentary keratitis associated with aqueous-deficient dry eye.","volume":"80","author":"Albietz","year":"2003","journal-title":"Optom Vis Sci"},{"issue":"Suppl 1","key":"R105-21-20210210","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/ICO.0b013e318228218c","article-title":"A practical treatment algorithm for managing ocular surface and tear disorders.","volume":"30","author":"Tseng","year":"2011","journal-title":"Cornea"},{"key":"R106-21-20210210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00003226-199603000-00004","article-title":"Effect of periocular humidity on the tear film lipid layer.","volume":"15","author":"Korb","year":"1996","journal-title":"Cornea"},{"key":"R107-21-20210210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0002-9394(14)73274-X","article-title":"The effect of wearing spectacles on the humidity of the eye.","volume":"108","author":"Tsubota","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"R108-21-20210210","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/scientificamerican0914-20b","article-title":"Dried up. Too much screen time linked to changes in tears.","volume":"311","author":"Maron","year":"2014","journal-title":"Sci Am"},{"key":"R109-21-20210210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199302253280817","article-title":"Dry eyes and video display terminals.","volume":"328","author":"Tsubota","year":"1993","journal-title":"N Engl J Med"},{"key":"R110-21-20210210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICU.0b013e32836227bf","article-title":"Hormones and dry eye syndrome: an update on what we do and dont know.","volume":"24","author":"Rocha","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"R111-21-20210210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-5122(00)00181-X","article-title":"Treatment of keratoconjunctivitis sicca with topical androgen.","volume":"37","author":"Worda","year":"2001","journal-title":"Maturitas"},{"key":"R113-21-20210210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1442-9071.2004.00922.x","article-title":"Benzalkonium toxicity.","volume":"32","author":"Walker","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"key":"R114-21-20210210","first-page":"59","article-title":"An in vitro method which assesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents.","volume":"6","author":"Lazarus","year":"1989","journal-title":"Lens Eye Toxic Res"},{"key":"R115-21-20210210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/15569529109057909","article-title":"Toxicity of ingredients in artificial tears and ophthalmic drugs in a cell attachment and spreading test.","volume":"10","author":"Salonen","year":"1991","journal-title":"J Toxicol Cutaneous Ocul Toxicol"},{"key":"R116-21-20210210","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0886-3350(98)80237-X","article-title":"Corneal sensation after cataract and refractive surgery.","volume":"24","author":"Kohlhass","year":"1998","journal-title":"J Cataract Refract Surg"},{"key":"R117-21-20210210","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0161-6420(03)00100-3","article-title":"Effect of hinge position on corneal sensation and dry eye after LASIK.","volume":"110","author":"Donnenfeld","year":"2003","journal-title":"Ophthalmology"},{"key":"R118-21-20210210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1475-1313.2008.00539.x","article-title":"Changes in corneal sensitivity and tear physiology after phacoemulsification.","volume":"28","author":"Khanal","year":"2008","journal-title":"Ophthalmic Physiol Opt"},{"key":"R119-21-20210210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10384-012-0117-8","article-title":"Changes in the tear film and ocular surface after cataract surgery.","volume":"56","author":"Oh","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"R120-21-20210210","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jcrs.2015.06.036","article-title":"Evaluation of dry eye after femtosecond laser-assisted cataract surgery.","volume":"41","author":"Yu","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R121-21-20210210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-0420.1999.770203.x","article-title":"Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy.","volume":"77","author":"Tomas-Barberan","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"R122-21-20210210","first-page":"1129","article-title":"Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery.","volume":"118","author":"Lin","year":"2000","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335019302421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335019302421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2019.03.023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:36:51Z","timestamp":1623782211000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02158034-201905000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2019.03.023","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An algorithm for the preoperative diagnosis and treatment of ocular surface disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Cataract & Refractive Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrs.2019.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ASCRS and ESCRS Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}